Atlas Trials

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Clinical trial NCT00752206 · TERMINATED

Trial details

NCT number
NCT00752206
Sponsor
Sarcoma Alliance for Research through Collaboration
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Osteosarcoma
Start date
2009-03-01
Primary completion
2017-08-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.